Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis

Bivalirudin vs . heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta‐analysis

(2022) Mei‐juan Li et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis

(2022) Liyao Liu et al.   PHARMACOLOGICAL RESEARCH

Coagulation activation during extracorporeal membrane oxygenation (ECMO)

(2022) Wayne L. Chandler   THROMBOSIS RESEARCH

Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review

(2021) Janos Geli et al.   JOURNAL OF INTENSIVE CARE MEDICINE

Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)

(2021) Joseph E. Tonna et al.   ASAIO JOURNAL

Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation

(2021) Troy G. Seelhammer et al.   CRITICAL CARE MEDICINE

Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO)

(2021) Shubhi Kaushik et al.   PERFUSION-UK

Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation

(2021) Erica A. Sheridan et al.   ASAIO JOURNAL

Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis

(2021) Di-huan Li et al.   THROMBOSIS RESEARCH

Eleven Years of Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: From H1N1 to SARS-CoV-2. Experience and Perspectives of a National Referral Center

(2021) Marina Pieri et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation

(2020) Haya Kaseer et al.   JOURNAL OF CARDIAC SURGERY

Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation

(2020) Mohammed Hamzah et al.   Pediatric Critical Care Medicine

Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high‐volume center

(2020) Matthew R. Schill et al.   ARTIFICIAL ORGANS

Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation

(2020) Desiree S. Machado et al.   ASAIO JOURNAL

SHOULD DIRECT THROMBIN INHIBITORS BE THE ANTICOAGULANT OF CHOICE FOR PATIENTS ON EXTRACORPOREAL MEMBRANE OXYGENATION?

(2020) H. Muller Moran et al.   CANADIAN JOURNAL OF CARDIOLOGY

Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation

(2020) Lindsay M. Ryerson et al.   Pediatric Critical Care Medicine

A Palpable Pulse Should Not Dictate Blood Pressure Strategy in Patients with Continuous Flow Ventricular Assist Devices

(2019) Jennifer A. Beckman et al.   ASAIO JOURNAL

Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy

(2019) Shea Macielak et al.   PERFUSION-UK

Single-center experience of extracorporeal membrane oxygenation mainly anticoagulated with nafamostat mesilate

(2019) Woosik Han et al.   Journal of Thoracic Disease

Heparin‐induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants

(2019) Uri Pollak   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature

(2019) Ellen Colman et al.   Journal of Thoracic Disease

Low-Dose Prothrombin Complex Concentrate in Patients with Left Ventricular Assist Devices

(2018) Caitlin S. Brown et al.   ASAIO JOURNAL

Exercise Capacity in Patients with the Total Artificial Heart

(2018) Justin M. Canada et al.   ASAIO JOURNAL

234

(2018) Mohammed Hamzah et al.   CRITICAL CARE MEDICINE

Veno-arterial-ECMO in the intensive care unit: From technical aspects to clinical practice

(2018) Arthur Le Gall et al.   Anaesthesia Critical Care & Pain Medicine

Opening the “Dor,” Not Always an Inferior Approach

(2018) Sugat Wagle et al.   ASAIO JOURNAL

Bivalirudin and ECLS

(2018) Troy G. Seelhammer et al.   ASAIO JOURNAL

855

(2018) Amin Demerdash et al.   CRITICAL CARE MEDICINE

Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies

(2017) Edis Ljajikj et al.   Interactive Cardiovascular and Thoracic Surgery

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support

(2017) Mario Menk et al.   Annals of Intensive Care

Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation

(2017) Theodore J. Berei et al.   ASAIO JOURNAL

Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin

(2016) Ju Yong Lim et al.   ANNALS OF THORACIC SURGERY

151

(2016) Courtney Khouli et al.   CRITICAL CARE MEDICINE

Evaluation of Systemic Heparin vs. Bivalrudin Anticoagulation in Patients Supported by Extracorporeal Membrane Oxygenation

(2016) T.J. Berei et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Extracorporeal Membrane Oxygenation—Hemostatic Complications

(2015) Deirdre A. Murphy et al.   TRANSFUSION MEDICINE REVIEWS

Bivalirudin Versus Heparin as an Anticoagulant During Extracorporeal Membrane Oxygenation: A Case-Control Study

(2012) Marina Pieri et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation

(2011) Sang Jin Han et al.   JOURNAL OF KOREAN MEDICAL SCIENCE